Moore Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-100,000
Closed -$6.72M 276
2015
Q2
$6.72M Sell
100,000
-150,000
-60% -$9.79M 0.14% 149
2015
Q1
$14.6M Buy
+250,000
New +$15.1M 0.32% 63

Other funds holding ABBV

Moore Capital Management's ABBV Position: Q4 2025 in Review

Moore Capital Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 60,000 shares — an estimated $13.9M sold.

Moore Capital Management first reported a position in ABBV in Q2 2014 and held it in 10 quarters. The position peaked at $19.2M in Q4 2021. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Moore Capital Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Moore Capital Management sold 60,000 AbbVie shares in Q4 2025, an estimated $13.9M.
  • Moore Capital Management first reported a position in AbbVie in Q2 2014 and held it in 10 quarters.
  • Moore Capital Management's AbbVie position peaked at $19.2M in Q4 2021.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Moore Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.